Epistaxis screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 2: Line 2:
{{Epistaxis}}
{{Epistaxis}}
{{WikiDoc CMG}}; {{AE}} [[User:Amir Bagheri|Amir Behzad Bagheri, M.D.]]
{{WikiDoc CMG}}; {{AE}} [[User:Amir Bagheri|Amir Behzad Bagheri, M.D.]]
==Screening==
 
In the possibility of coagulopathy , screening tests like [[CBC]], [[PT]], [[PTT]] must be performed to prevent epistaxis or find the cause of nose bleeding.<ref name="KrulewitzFix2019">{{cite journal|last1=Krulewitz|first1=Neil Alexander|last2=Fix|first2=Megan Leigh|title=Epistaxis|journal=Emergency Medicine Clinics of North America|volume=37|issue=1|year=2019|pages=29–39|issn=07338627|doi=10.1016/j.emc.2018.09.005}}</ref>
<br />
==References==
 
== Overview ==
No screening is indicated for epistaxis in asymptomatic patients.
 
= Screening =
No screening is indicated for epistaxis in asymptomatic patients.
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}

Revision as of 20:17, 17 October 2020